Roche buys diabetes app-maker mySugr in digital health push
ZURICH: Swiss drugmaker Roche said on Friday it is buying Vienna-based diabetes management platform mySugr for an undisclosed price as it presses into app-based digital health services for people suffering from the metabolic disorder.
MySugr, a privately held company that offers a logbook for mobile devices to help people manage their disease, had previously got funding from the Roche Venture Fund, Roche said in a statement.
Roche is among the world's largest makers of diabetes diagnostics, including finger pricks for patients to determine blood sugar levels.
(Reporting by John Miller; Editing by Michael Shields)
Acquisitionblood sugar levelsdiabetesfundingMetabolic Disordersmobile devicesmySugrRocheRoche Venture Fund
Source : REUTERSNext Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd